May 14, 2024

Dr. Heinz-Jürgen Bertram

Symrise continues growth course in the first half of 2023

Organic sales growth of 8.0 % in the first six monthsSales in the reporting currency in the first half of the year 6.8 % versus yearNormalized EBITDA margin of 19.7 % remains at a good levelGrowth target for 2023 confirmed at 5% to 7% / normalized EBITDA margin of around 20% targeted Symrise continued its